TP53 and chronic kidney disease: The remarkable effects of LIPUS treatment on inhibiting increases in the renal p53, p16, and p21 protein expression and the serum levels of FGF-23 and restoring deficiencies in the renal Klotho protein after IRI-associated CKD were shown in this study.